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Background: In 2002, Disease Management Programs (DMPs) were introduced within the German healthcare
system with the aim to increase the quality of chronic disease care. Due to the enrollment procedures, it can be
assumed a) that only certain patients actively decide to enroll in a DMP and/or b) that only certain patients get the
recommendation for DMP enrollment from their physician. How strong this assumed effect of self- and/or professional
selection is, is still unclear.
Methods: We used data from a cross-sectional postal-survey linked on individual level with administrative claims data
from a German sickness fund. The sample consisted of individuals suffering from coronary heart disease (CHD) who i)
were either enrolled in the respective DMP or ii) fulfilled the disease related criteria for enrollment but were not enrolled.
We applied multivariate logistic regression analyses to assess factors on patient level associated with DMP enrollment.
Results: We included 7070 individuals in our analyses. Male sex, higher age and receiving old age pension, a higher
Charlson Score and a diagnosis of type 2 diabetes increased the odds for DMP-CHD enrollment significantly. Individuals
with a diagnosed myocardial infarction (MI) were also more likely to be enrolled in the DMP-CHD. We found a significant
interaction effect for MI and sex, indicating that the association between MI and DMP enrollment is stronger for women
than for men.
Conclusion: DMP-enrollees and non-enrollees differ in various factors. Studies analyzing the effectiveness of DMP-CHD
should carefully take into account these group differences. Furthermore, the results suggest that the DMP-CHD assessed
reaches men better than women.
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In the year 2002, Disease Management Programs
(DMPs) were introduced within the German healthcare
system, initially for diabetes and breast cancer. The aim
was to increase the quality of chronic disease care, based
on the provision of coordinated and structured care,
following clinical guidelines and by strengthening the
patients’ self-care competencies [1].
The first DMPs for coronary heart disease (CHD) were
introduced in 2003. By 2014, more than 1.7 million indi-
viduals were enrolled in a DMP-CHD [2]. DMPs for
CHD aim specifically at: the reduction of mortality; the
reduction of cardiovascular morbidity (a reduction of
myocardial infarctions (MI) and a reduction in the de-
velopment of heart failure); and an increase in quality of
life [3]. Enrollment in the DMP-CHD is voluntary and
without any costs for statutorily health insured. Patients
can enroll in the DMP-CHD if they have a documented
diagnosis of CHD and are willing to actively participate
in the DMP [2].
Due to the enrollment procedures, it can be assumed
a) that only certain patients actively decide to enroll in a
DMP and/or b) that only certain patients get the recom-
mendation for DMP enrollment from their physician.
How strong the effect of self- and/or professional selec-
tion is, is still unclear. Comprehensive information on
selective enrollment in DMPs is essential for research as
well as policy making. First of all, it is important to
know if certain population subgroups are not reached
although they might benefit from DMPs. Secondly,
selective enrollment might influence the results of DMP
evaluation [4] and studies trying to evaluate DMPs face
the difficulty of selecting suitable control groups [5].
This becomes more important when considering that
14 years after the introduction of DMPs, methodologic-
ally solid evidence on their effectiveness is still limited
[6]. The mandatory program evaluation according to
clause 137f, paragraph 4 in Book Five of Germany’s So-
cial Security Code (SGB V), includes DMP enrollees
only, thus a control group is missing and inferences on
the effectiveness of DMPs cannot be made.
To overcome the assumed selection bias, many studies
analyzing the effectiveness of DMPs apply propensity
score matching [5, 7–10]. Yet, those studies often use
routinely collected administrative claims data only, and
thus, some factors potentially influencing DMP enroll-
ment cannot be included. For instance, it is still rather
unclear, how socio-economic factors influence DMP
enrollment [11, 12]. On the other hand, analyses relying
on survey data only, face the problem of incorrect or
incomplete reporting [13].
Most studies on DMPs focused on the DMP for type 2
diabetes (DM2) [4, 6, 9, 14–17]. Little is known about
the effects of selective enrollment within the DMP-CHD. To our knowledge, only three publications ana-
lyzed selective enrollment in the DMP-CHD. The study
by Gapp et al. [18] used data from a MI register, which
includes individuals with an acute MI living in the
region of Augsburg, southern Germany. Eligible individ-
uals were surveyed and patient characteristics were, if
possible, cross-checked with registry data. The study
indicated that the odds for DMP enrollment decreased
with age and with the time since the last MI. Patients
suffering additionally from DM2 were more likely en-
rolled than those with a cardiac event only [18]. The two
publications by Bozorgmehr et al. [11, 12] used data
from a cohort study conducted in the German federal
state of Saarland. Study participants had either a diagno-
sis of MI and/or angina pectoris. The focus in both ana-
lyses was on inequities in DMP enrollment by education
and regional deprivation. In Bozorgmehr et al. [11] the
authors reported no horizontal inequities regarding edu-
cational attainment, but found that women living in
less-deprived areas were significantly more likely to
enroll in the DMP-CHD than women in deprived areas.
In Bozorgmehr et al. [12] they reported that women gen-
erally are less likely to enroll in the DMP-CHD than
men but found no effect for education.
The aim of our analyses is to add further knowledge
on selective enrollment in the DMP-CHD by identifying
factors on patient level that are associated with DMP en-
rollment. We try to overcome the discussed shortcom-
ings by using a database of survey data linked with
individual level claims data by a German sickness fund
and by including chronically ill from all federal states of
Germany.
Methods
Data/sample
Within the project RAC (Responsiveness in ambulatory
care [19]), a German-wide postal survey with chronically
ill individuals was conducted in October 2013. The sam-
ple consisted of persons having CHD who i) were either
enrolled in the respective DMP or ii) fulfilled the disease
related criteria for enrollment but were not enrolled.
The sample was identified based on claims data by a
German sickness fund (Techniker Krankenkasse (TK));
from both groups a random sample of 12,999 (not en-
rolled) and 13,000 (enrolled) individuals was drawn
based on defined in- and exclusion criteria (see Table 1).
All identified individuals were contacted via post and
received the questionnaire, a letter of informed consent
regarding the use of administrative claims data and add-
itional informational material (e.g., on data protection
issues). Data were only linked and included in the fol-
lowing analyses if both the questionnaire and the signed
informed consent were returned. The final dataset com-
prises i) data from the 2013 postal survey that is linked
Table 1 Inclusion and exclusion criteria
Inclusion Exclusion
For all groups
• 18 to 90 years at date of initial sample selection (23.9.2013)
• Continuously insured at the TK (from 1.1.2012-23.10.2013)
• The insured with increased data security regulation (e.g.,
former employees of TK)
• The insured who are unable to participate in a written
survey (e.g., person with legal representative)
• Further TK standards (e.g., insured person was contacted
for a different survey within last 12 months by TK)
DMP Participants (initial sample n = 13,000)
• Continuously enrolled in indication specific DMP (from 1.1.2012-23.10.2013)
Non-DMP-Participants (initial sample n = 12,999)
Minimum requirement for identification of coronary heart disease patients
based on claims data:
• one selected ICD-code (I20-I25, I50) from hospital care within last 36 months
OR
• one selected ICD-code (I20-I25, I50) from ambulatory care AND one of the
selected ATC-codes (C01DA02, C01DA05, C01DA08, C01DA14, C01DA52,
C01DX11, C01DX12, C07AA03, C07AA05, C07AA07, C07AB02, C07AB03,
C07AB05, C07AB07, C07AB08, C07AB12, C07AB13, C07AG02, C09AA01 - C09AA11,
C09BA01 - C09BA09, C09BB05, C09BB10) within last 12 months
OR
• One selected ATC-code (C01DA02, C01DA05, C01DA08, C01DA14, C01DA52,
C01DX11, C01DX12) within last 12 months
• Enrollment in any other DMP (1.1.2012-23.10.2013)
Source: Röttger et al. 2015 [19]
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ing 18 months (from April 2012 to September 2013).
Due to the fact that the sample is from one German
sickness fund only, it has to be assumed that the results
are not representative for the overall German population
suffering from CHD. The sample selection, the linkage
of survey and claims data as well as the operationaliza-
tion of variables (including the used ICD-codes) are
discussed in more detail in Röttger et al. [19].
Analyses
We used binary logistic regression analysis to assess
factors associated with DMP enrollment. In the multi-
variate analysis we specified five models that varied by
the included explanatory variables.
Variable description and rationale for variable selection
DMP enrollment: The status of DMP enrollment was
generated from administrative claims data. Enrollment
was defined as an individual being continuously enrolled
in the DMP-CHD since at least 1.1.2012. Individuals
within the group “not enrolled” were not enrolled in the
DMP-CHD nor in any other DMP (e.g., for DM2) since
at least 1.1.2012.
Socio-demographic and socio-economic factors: The
following variables were included in all models: Sex, age,
living area (urban vs. rural), net equivalent income,
employment status and single household. In addition to
these “objective” factors, we also included a variableindicating the subjective socio-economic status
(subSES). The variables net equivalent income, employ-
ment status, single household and subSES were based
on survey data. We calculated the net equivalent income
by dividing the monthly net income by the number of
household members, weighing the first member with 1
and all other family members with 0.5 [19].1
Enrolled in integrated care program: Enrollment in an
integrated care program (e.g., in a family physician care
model) was assessed from claims data. In contrast to
DMPs that primarily focus on the ambulatory care level,
integrated care programs mainly aim at cross-sector
patient care [20]. We assumed that participants of inte-
grated care programs are more likely to be enrolled in a
DMP for two reasons: a) they might be more positive
about participating in structured care programs in gen-
eral; and/or b) may have a GP who is more positive
about special care programs in general and is thus more
likely to promote DMP enrollment.
Co-Morbidity – generic: As previous studies had dis-
cussed that DMP-participants are healthier than non-
participants [15], we included various measures of (co-)
morbidity: the level of long term care entitlement, the
Charlson Score and self-rated health on a scale from 0
(worst imaginable state) to 100 (perfect health). We cal-
culated the ambulatory version of the Charlson Score
[21] based on administrative claims data.2 All diagnoses,
on which variables are based, were identified through
ICD-10-Codes from ambulatory and hospital care.
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disease specific morbidity measures: i) a diagnosis of
DM2, ii) the level of disease severity, iii) a MI and iv) a
congestive heart failure (CHF) diagnosis. DM2 was se-
lected for two reasons: a) it is a frequent comorbidity of
CHD and b) a DMP for DM2 exists and thus, persons
suffering from CHD and DM2 have a higher chance of
being informed about DMPs. The level of disease sever-
ity comprised three categories (lowest severity: CHD,
other ischemic heart diseases; medium severity: angina
pectoris, after MI and without a previous MI; highest se-
verity: acute MI, unstable angina pectoris, other acute is-
chemic heart diseases). The classification was conducted
based on the morbidity-categories and ICD diagnoses
used by the German Federal (Social) Insurance Author-
ity [22]. Additionally we included a variable indicating a
MI (acute and history of MI) and a variable indicating
CHF. Previous studies reported an association between
MI and DMP enrollment [11]. Moreover, as the DMP
for CHD is offered with an additional module for CHF
[2], we assumed that DMP enrollment might be espe-
cially interesting for persons suffering from CHF.
A gender bias in the treatment of CHD is frequently dis-
cussed, with women and men being treated differently
and a greater focus of attention on the treatment of men
[23, 24]. We thus included interaction terms between sex
and all CHD specific variables (MI, CHF, disease severity).
Incomplete data, missing values and plausibility checks
Cases with incomplete (only questionnaire or only ad-
ministrative claims data) or implausible data (e.g., differ-
ent information on age and sex in questionnaire and
administrative data) were excluded from all analyses.
For enrollment in the DMP-CHD a diagnosis of CHD
is required. Therefore we only included cases which had
according to our data at least one diagnosis related toTable 2 Analysis (non-) responder
Enrolled in DMP Not Enrol
initial
sample
linked
sample
response
rate
initial
sample
Sex
Female 2,957 952 32.19% 5,002
Male 10,043 4,189 41.70% 7,997
Age
< =60 years 1,963 502 25.57% 4,282
61–65 years 1,474 463 31.41% 1,711
66–70 years 1,959 782 39.92% 1,587
71–75 years 3,158 1,412 44.71% 2,389
76–80 years 2,611 1,234 47.22% 1,669
> 80 years 1,835 748 40.76% 1,361
Total 13,000 5,141 39.55% 12,999CHD. Cases without a diagnosis of CHD may have been
in the initially selected sample for two reasons: a) for the
sample selection a broader time frame was used and b) a
rather sensitive approach was used to identify CHD
patients (increasing the chance of “false-positive” cases).
We handled missing values in survey data by using
multiple imputation. We imputed 15 datasets by fully
conditional specification with multinomial logit models
and predictive mean matching [25, 26]. All analyses were
conducted with the original and the imputed dataset.
Except for the descriptive statistics, we only report the
results from the imputed datasets. For the logistic re-
gression we report pooled estimates; for all analyses we
report a significance level of p < 0.05. The multiple im-
putation was conducted in R (package MICE), the re-
gression analysis in SPSS 22. All study participants gave
written informed consent. The study was approved by
the responsible ethics committee.
Results
From 25,999 contacted persons, 8476 persons returned a
filled in questionnaire, the signed consent form for data
linkage and the linked cases passed the plausibility
checks. These cases were included in a (non-) responder
analysis, which revealed that DMP-participants, men
and older study participants returned questionnaire and
consent form more frequently (see Table 2). The re-
sponse rates across sex and age groups were similar
within the groups enrolled in DMP and not enrolled.
However, the rise in response rates with age was steeper
in the enrolled in DMP group compared to those not
enrolled.
Of those 8476 that returned the questionnaire and the
consent form, 1407 individuals did not fulfil the official
requirement for DMP participation, as they had no rele-
vant diagnosis related to CHD within the six quartersled Total
linked
sample
response
rate
initial
sample
linked
sample
response
rate
1,177 23.53% 7,959 2,131 26.77%
2,158 26.99% 18,040 6,345 35.17%
790 18.45% 6,245 1,292 20.69%
440 25.72% 3,185 902 28.32%
434 27.35% 3,546 1,216 34.29%
809 33.86% 5,547 2,220 40.02%
527 31.58% 4,280 1,763 41.19%
335 24.61% 3,196 1,083 33.89%
3,335 25.66% 25,999 8,476 32.60%
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analyses. From those cases that had to be excluded due
to not meeting the required diagnosis, 1377 were not
enrolled in a DMP and only 30 were enrolled.
In the final sample of 7070 cases, 1092 had one or
more missing values that were imputed and subse-
quently included in all further analysis. Eighty two per-
cent of the imputed sample are male and the mean age
is 71.4 (min: 25, max: 90, SD: 9.1) years. The majority of
participants lives in a two person household, receives
old-age pension, has a net equivalent income between
980€ and 1633€ (i.e., 60–100% of German median) and
rates themselves as having a medium socio-economic
status (see Table 3).
Persons enrolled in a DMP have more frequently a
reported MI, CHF and a higher number of comorbidities
according to the Charlson Score. Considering that all
participants suffer from a chronic disease, the self-rated
health (mean: 64.5; median: 70) is still rather good (the
mean value of the German population was 77.4 in a
representative survey in 2002/2003 [27]).
Multivariate analyses
In the multivariate analyses five binary logistic regression
models with varying explanatory variables were specified.
Due to the previous imputation of missing values, all
models included the full sample of 7070 cases.
Socio-demographic and socio-economic factors: Male
sex, higher age and receiving old age pension have
higher odds for DMP enrollment in all five models
(Table 4). While we found a slight association in Model
1 and 2 between the net equivalent income and DMP
enrollment, the association is insignificant when control-
ling for co-morbidities.
Integrated care program: The enrollment in an inte-
grated care program significantly increases the odds of
being enrolled in a DMP (OR: 1.54–1.57, p < 0.05).
Co-Morbidity – generic: Individuals with higher Charl-
son Scores, i.e., those with at least two or those with
more severe co-morbidities, are more likely to be en-
rolled. Yet, this effect vanishes for those with even more
comorbidities (Charlson Score above 3).
(Co-) Morbidity – disease specific: Individuals with a
diagnosed DM2 and individuals with a diagnosed MI
have higher odds for DMP enrollment (OR: 2.65, p < 0.05;
OR: 2.15, p < 0.05). Yet, a high disease severity according
to the classification of the German Federal (Social) Insur-
ance Authority significantly decreases the odds for DMP
enrollment (OR: 0.49–0.65, p < 0.05).
Interaction effects: In addition to the single effects,
we find a strong significant interaction effect between
MI and sex. While a MI increases the odds of being
enrolled in a DMP, the effect is stronger for women
than for men. This effect is illustrated in Fig. 1, whichdepicts the conditional probability for DMP enrollment,
by sex and MI.
We conducted the same analyses with the dataset
without imputed values using complete case analysis. In
these analyses 5978 cases were included and the results
were very similar to the results with the imputed
dataset.
Discussion
The aim of this analysis was to identify factors on pa-
tient level that are associated with DMP enrollment.
Based on administrative claims data of a large German
sickness fund, the two groups “DMP-enrollee” and “not
enrolled, but fulfills criteria for DMP enrollment” were
determined. From these two groups, a random sample
each was drawn. Thus, assuming the enrollees and non-
enrollees do not differ systematically regarding their
characteristics, one could expect to find no differences
between the two selected groups. At the same time, it
can be assumed that differences between the groups in-
dicate that these are either due to “selective enrollment”
or that the DMP participation/non-participation led to
these differences.
We found significant effects for age and sex, with
higher age and a male sex increasing the odds for DMP
enrollment. Our findings regarding sex are consistent
with the results reported by Bozorgmehr et al. [12].
However, both findings are different to the study results
by Gapp et al. [18]. The differences in the effect of age
are probably due to the year of the survey/study (2006
vs. 2013). While the DMP-CHD was still rather new
during the survey of Gapp et al., individuals suffering
from CHD had have up to 9 years to enroll in the DMP
at the point of our study. Differences considering the
gender distribution (Gapp et al. did not find a significant
association between sex and enrollment) are probably
resulting from distinct CHD morbidities [18]. While the
study by Gapp et al. [18] included exclusively individuals
with a history of a MI, we find that differences between
men and women are especially strong for those who did
not have a diagnosed MI.
As assumed, the association between disease severity
and DMP enrollment is affected by the patient’s sex: for
women the association between MI and DMP enroll-
ment is a lot stronger than the same association for
men. Thus, it seems that women need a worse disease
state then men, before they consider or are asked to
enroll in the DMP-CHD. These results support exist-
ing studies focusing on gender differences in health
care settings and particularly in the treatment of
CHD [23, 28].
Further morbidity indicators are significantly associ-
ated with DMP enrollment: a higher level of disease se-
verity decreased the odds for DMP enrollment whereas
Table 3 Sample characteristics, divided by enrollment-status, re-
ported in % (values after multiple imputation)
Variable Enrolled in
DMP
N = 5103
Not-Enrolled
N = 1967
Total
N = 7070
Socio-demographic and socio-economic factors
Male 81.6 73.7 79.4
Age in years (mean) 72.37 ± 8.40 68.72 ± 10.35 71.36 ± 9.13
Net equivalent incomea
< =979€ 13.0 (14.6) 13.5 (15.0) 13.2 (14.7)
980 to 1633€ 46.2 (49.6) 38.9 (42.2) 44.2 (47.5)
> 1633 to <2449€ 24.0 (25.7) 25.3 (27.1) 24.4 (26.1)
= > 2449€ 9.4 (10.1) 14.6 (15.8) 10.8 (11.7)
Missing 7.5 7.7 7.5
Employment/retirement statusa
Old-age pension 80.8 (82.7) 66.0 (67.6) 76.6 (78.5)
Employed 11.1 (11.5) 23.6 (24.4) 14.6 (15.1)
Not-employed 5.5 (5.8) 7.4 (8.0) 6.0 (6.4)
Missing 2.7 3.1 2.8
Subjective socio-economic statusa
Lowest subSES 19.5 (21.2) 17.8 (19.4) 19.0 (20.7)
Medium subSES 58.8 (63.4) 59.5 (63.6) 59.0 (63.4)
Highest subSES 14.3 (15.4) 15.7 (17.0) 14.7 (15.8)
Missing 2.9 3.0 2.9
Other/None of
these subSES
4.5 4.1 4.4
Urban living area 76.6 76.1 76.5
Single householda
1 person in household 15.4 (16.0) 15.3 (15.7) 15.4 (15.9)
> 1 person in
household
82.4 (84.0) 82.7 (84.2) 82.5 (84.1)
Missing 2.2 2.0 2.1
Integrated care
Enrolled in integrated
care program
12.5 8.3 11.3
Co-Morbidity - generic
Level of long term care entitlement
No entitlement 96.6 97.3 96.8
Level 1 2.7 1.8 2.5
Level 2 0.7 1.0 0.7
Charlson Score
Charlson Score = 0 10.8 16.8 12.5
Charlson Score = 1 19.9 25.5 21.5
Charlson Score = 2 19.5 18.7 19.3
Charlson Score = 3 16.6 14.6 16.1
Charlson Score > 3 33.1 24.5 30.7
Table 3 Sample characteristics, divided by enrollment-status, re-
ported in % (values after multiple imputation) (Continued)
Self-reported health
status – Value on
VAS (median/mean)
70/64.2 ± 19.0
(n = 4,990)
(70/64.5)
70/65.4 ± 19.7
(n = 1,931)
(70/65.7)
70/64.5 ± 19.2
(n = 6,921)
(70/64.8)
(Co-) Morbidity – disease
specific:
Type 2 Diabetes 26.4 11.6 22.3
Disease Severity
Lowest severity 54.8 52.4 54.1
Medium severity 26.5 25.5 26.2
Highest severity 18.7 22.2 19.7
Myocardial Infarction (MI) 33.4 27.1 31.7
Congestive heart failure
(CHF)
30.7 28.2 30.0
aInformation from survey data; all other variables derived from administrative
claims data; values in brackets = values after multiple imputation; ± standard
deviation
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the DMP-CHD seems to be especially interesting for pa-
tients with a low severity of CHD and for patients who
suffered from a MI. In contrast, suffering from unstable
angina pectoris (disease severity high) reduces the odds
for DMP enrollment. This effect might be explained by
the initial aims of the DMP, which is to help patients
managing their disease and to avoid a worsening of the
disease. Thus, those who are still in a lower disease sever-
ity might have a better chance to profit from the DMP en-
rollment than those with a high severity (e.g., patients that
already suffer from unstable angina pectoris). In addition,
the required “active participation” of the patients for DMP
enrollment, might be a barrier for very ill patients.
The results indicate a strong association for DM2
and DMP-CHD enrollment. As previously discussed,
this is probably due to the fact that a DMP program
for DM2 exists, and thus, the chances to get to know
about DMPs at all are higher for individuals having
both conditions.
Employment status and DMP enrollment also correl-
ate, with employed individuals being less likely to enroll
in a DMP. A possible reason is that employed individ-
uals cannot spend or do not want to spend as much
time with their disease management as, for instance, in-
dividuals receiving old-age pension. This explanation is
supported by studies showing that employed individuals
also report to forgo care more often than others [29].
In the interpretation of our results several limitations
have to be considered. First of all, although the study in-
cludes patients from all over Germany, all of them are
insured at one sickness fund (TK). Hence, our sample is
not representative of all CHD patients in Germany, and
the generalizability of our results may be limited [30]. In
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Fig. 1 Conditional probability for DMP enrollment by sex and MI
Röttger et al. BMC Health Services Research  (2017) 17:246 Page 9 of 11addition, our results might be affected by differences in
the survey-response behavior. It is possible that certain
groups of patients did not participate in our study e.g.,
very ill individuals. However, we were able to analyze the
(non-) response rates for age, sex and DMP enrollment.
These revealed an overall higher response rate for in-
dividuals enrolled in a DMP, but the comparison of
the response rates in relation to sex and age split by
DMP enrollment status, showed rather similar results
(e.g., women had in both groups a lower response
rate than men).
We used cross-sectional survey data from October
2013 and administrative claims data from 01 April 2012
to 30 September 2013, while the date of DMP enroll-
ment was any time before 01 January 2012. Thus, for
some variables we do not know if they influence the
DMP enrollment or if enrollment influences the occur-
rence of e.g., a certain diseases. Yet, it is rather unlikely
that e.g., DMP enrollment leads to more MI in women.
The interpretation that women are more frequently
enrolled if they had a history of MI seems therefore le-
gitimate. As in all analyses using administrative claims
data, it has to be considered that the primary reason for
data collection was different to the aim of the conducted
analyses. Especially in the comparison of DMP-enrollees
and non-enrollees it has to be considered that the med-
ical documentation for patients within a DMP might be
slightly better.
Conclusion
This is the first study that comprehensively analyses the
association between patient characteristics and DMP-
CHD enrollment for patients from all over Germany. Al-
though this study focuses solely on selective enrollment
within German DMPs, selective enrollment may also
exist in other voluntary care programs (e.g., in the con-
text of integrated care). As care programs address apredefined target population, some intended selection
effects are desirable. The problem of adverse selective
enrollment arises when the selection effects are not the
defined target effects but disadvantage certain popula-
tion groups.
The results indicate that DMP-enrollees and non-
enrollees differ in various factors, e.g., sex, age,
employment-status, (co-) morbidities and that selective
enrollment may exist. Studies evaluating the DMP-CHD
should carefully take into account the differences be-
tween both groups. The results indicate that the CHD
assessed reaches men better than women. These findings
needs further evaluation, as they suggest that the pro-
gram either suits men better than women or that it is
promoted to men more successfully than to women.
Endnotes
1We did not differentiate between adults and children
under 14 years of age (as it is done in the modified
OECD scale [31]), as the survey only included a question
regarding the number of children under 18 years of age.
But due to the high mean age of the sample, we assume
a very small number of under 14 year old children in
our sample.
2We excluded the diseases MI, CHF and DM2 from
the calculation of the Charlson Score.
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